IKT
Price
$1.95
Change
-$0.00 (-0.00%)
Updated
Jul 1, 04:59 PM (EDT)
Capitalization
144.97M
VERV
Price
$11.28
Change
+$0.04 (+0.36%)
Updated
Jul 1, 02:57 PM (EDT)
Capitalization
1B
37 days until earnings call
Interact to see
Advertisement

IKT vs VERV

Header iconIKT vs VERV Comparison
Open Charts IKT vs VERVBanner chart's image
Inhibikase Therapeutics
Price$1.95
Change-$0.00 (-0.00%)
Volume$3.13K
Capitalization144.97M
Verve Therapeutics
Price$11.28
Change+$0.04 (+0.36%)
Volume$4.31K
Capitalization1B
IKT vs VERV Comparison Chart in %
Loading...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IKT vs. VERV commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IKT is a Buy and VERV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (IKT: $1.95 vs. VERV: $11.23)
Brand notoriety: IKT and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IKT: 149% vs. VERV: 64%
Market capitalization -- IKT: $144.97M vs. VERV: $1B
IKT [@Biotechnology] is valued at $144.97M. VERV’s [@Biotechnology] market capitalization is $1B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IKT’s FA Score shows that 1 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • IKT’s FA Score: 1 green, 4 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, VERV is a better buy in the long-term than IKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IKT’s TA Score shows that 5 TA indicator(s) are bullish while VERV’s TA Score has 7 bullish TA indicator(s).

  • IKT’s TA Score: 5 bullish, 3 bearish.
  • VERV’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, VERV is a better buy in the short-term than IKT.

Price Growth

IKT (@Biotechnology) experienced а +17.47% price change this week, while VERV (@Biotechnology) price change was +1.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.51%. For the same industry, the average monthly price growth was +32.88%, and the average quarterly price growth was +3.93%.

Reported Earning Dates

IKT is expected to report earnings on May 14, 2025.

VERV is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-0.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($1B) has a higher market cap than IKT($145M). VERV YTD gains are higher at: 99.113 vs. IKT (-40.000). IKT has higher annual earnings (EBITDA): -39.54M vs. VERV (-201.62M). VERV has more cash in the bank: 497M vs. IKT (93.2M). IKT has less debt than VERV: IKT (74.8K) vs VERV (68.6M). VERV has higher revenues than IKT: VERV (59.6M) vs IKT (0).
IKTVERVIKT / VERV
Capitalization145M1B14%
EBITDA-39.54M-201.62M20%
Gain YTD-40.00099.113-40%
P/E RatioN/AN/A-
Revenue059.6M-
Total Cash93.2M497M19%
Total Debt74.8K68.6M0%
TECHNICAL ANALYSIS
Technical Analysis
IKTVERV
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRSAX26.020.01
+0.04%
MFS Research International A
NWCCX43.01N/A
N/A
Nuveen Winslow Large-Cap Growth ESG C
CMDYX13.60N/A
N/A
Columbia Mid Cap Index Inst3
NOLVX21.35N/A
N/A
Northern Large Cap Value
TSTFX20.23N/A
N/A
Transamerica Stock Index R4

IKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IKT has been loosely correlated with CRGX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IKT jumps, then CRGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
+20.37%
CRGX - IKT
43%
Loosely correlated
-1.67%
ARWR - IKT
34%
Loosely correlated
-1.68%
IDYA - IKT
34%
Loosely correlated
-1.64%
TRDA - IKT
32%
Poorly correlated
-2.75%
SYRE - IKT
31%
Poorly correlated
-1.64%
More

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with ACXP. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then ACXP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
-0.62%
ACXP - VERV
52%
Loosely correlated
+18.79%
CRSP - VERV
50%
Loosely correlated
+4.15%
BEAM - VERV
49%
Loosely correlated
+1.25%
IVEVF - VERV
46%
Loosely correlated
N/A
PRME - VERV
45%
Loosely correlated
+2.07%
More